Zdrowie i gospodarka · 19/06/2017

FDA Requests Public Comment on Proposed Collection of Information for Orphan Drug Designation

The Food and Drug Administration (FDA) is seeking public input on a proposed information collection related to the designation of orphan drugs, as required by the Paperwork Reduction Act of 1995.